Immune Amnesia and the Measles Paradox

Maurice Hilleman's Edmonston Chick-Embryo Strain and the Protection of Prior Memory

Across twentieth-century demographic records from England, the United States, Denmark, and sub-Saharan Africa, public health historians repeatedly encountered a quantitative anomaly that outstripped traditional disease-specific accounting. Whenever mass measles vaccination was introduced into a population, childhood mortality did not merely fall by the 10 to 15 percent attributable to acute measles pneumonia and encephalitis. Total all-cause childhood deaths from unrelated bacterial pneumonias, streptococcal sepsis, and diarrheal diseases dropped by 30 to 50 percent over the subsequent two to five years. For decades, epidemiologists debated whether measles vaccine exerted a nonspecific training boost on innate immunity or whether wild measles infection silently inflicted long-term collateral damage on the adaptive immune system.

Measles is caused by Morbillivirus hominis, an enveloped negative-sense RNA paramyxovirus that ranks among the most contagious human pathogens known, with a basic reproduction number $R_0$ between 12 and 18 in susceptible populations. In February 1954, pediatricians Thomas Peebles and John Enders isolated the virus at Boston Children's Hospital by inoculating primary human kidney cell cultures with blood and pharyngeal washings collected from schoolboy David Edmonston during an outbreak at the Fay School in Massachusetts. Although Enders attenuated the Edmonston-B strain through human kidney, amnion, and chick embryo passages to win licensure in 1963, the vaccine still provoked high fevers and rash in up to half of recipients unless co-administered with human gamma globulin. At Merck Sharp & Dohme in West Point, Pennsylvania, chief virologist Maurice Hilleman passaged the Edmonston strain forty additional times inside specific-pathogen-free chick embryo fibroblast monolayers incubated at a hypothermic $32^\circ\text{C}$. Those cold-adapted passages yielded the Moraten strain licensed in 1968. In 1971, Hilleman combined Moraten with the Jeryl Lynn mumps strain—isolated from his own daughter's throat swab in March 1963 and attenuated over seventeen passages in embryonated hen's eggs and chick fibroblasts—and Stanley Plotkin's human-diploid-cell rubella strain (RA 27/3) into the trivalent MMR vaccine.

The cellular mechanism behind the post-vaccine collapse in non-measles childhood mortality was uncovered between 2012 and 2019 through receptor tropism studies and high-throughput antibody profiling led by Rik de Swart, Michael Mina, and Stephen Elledge. Contrary to early assumptions that measles primarily infects respiratory epithelial cells at entry, wild-type measles virus uses its surface hemagglutinin (H) glycoprotein to bind with nanomolar affinity to SLAMF1 (Signaling Lymphocytic Activation Molecule Family Member 1, or $\text{CD150}$). Rather than sitting on airway epithelium, $\text{CD150}$ is expressed densely on the surfaces of alveolar macrophages, dendritic cells, thymocytes, and—most fatefully—activated and memory B lymphocytes and $\text{CD4}^+$ and $\text{CD8}^+$ memory T lymphocytes residing in the lymph nodes, spleen, and bone marrow.

During the prodromal incubation phase of natural measles, infected alveolar macrophages and dendritic cells ferry the virus straight into secondary lymphoid tissues. Once inside the lymph nodes, the virus infects and lyses the host's pre-existing pool of $\text{CD150}^+$ memory lymphocytes. Although total peripheral lymphocyte counts appear to rebound within weeks of the rash clearing, that numerical recovery is an immunological mirage. The replacement cells are overwhelmingly new measles-specific clones, while the diverse library of prior memory clones accumulated against Streptococcus pneumoniae, Staphylococcus aureus, rotaviruses, and respiratory syncytial virus has been physically ablated. If $D_0$ represents the breadth of a child's pre-existing pathogen-specific antibody epitope repertoire prior to infection and $f_{\text{lysed}}$ denotes the fraction of $\text{CD150}^+$ memory B-cell and long-lived plasma-cell clones destroyed during acute viremia, the surviving antibody repertoire diversity $D(t)$ at time $t$ after infection follows a depletion-and-re-exposure recovery law:

where $r(\tau)$ is the slow rate at which the child re-encounters endemic community pathogens to rebuild immunological memory from naive lymphocytes.

In 2019, Mina, Elledge, and de Swart quantified $f_{\text{lysed}}$ directly using VirScan phage-display immunoprecipitation sequencing (PhIP-Seq). They screened epitopes from more than four hundred human viruses and bacteria against paired serum samples drawn from 77 unvaccinated Dutch children before and seven weeks after a 2013 natural measles outbreak. Uninfected control children and MMR-vaccinated infants retained 100 percent of their baseline antibody repertoires, because attenuated vaccine strains replicate poorly in vivo and do not cause systemic lymphodepletion. In children who contracted wild measles, however, a single infection erased between 11 and 73 percent (with a median loss near 40 percent in severe cases) of their pre-existing antibody library, rendering them vulnerable for two to three years to secondary infections they had previously mastered.